CASTLEARK MANAGEMENT LLC

Position in ASND — Ascendis Pharma A/S

CIK 1106832 CHICAGO, IL

Position in ASND

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$16,455,557

+$989,750 QoQ

Shares Held

61,696

-8.8% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

#79

of 308 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CASTLEARK MANAGEMENT LLC holds $107,512,673 across 17 Biotechnology names. ASND ranks #2 (15.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	62,043	$19,611,171
2	ASND	Ascendis Pharma A/S This page	61,696	$16,455,557
3	JAZZ	Jazz Pharmaceuticals plc	46,920	$11,306,312
4	TGTX	Tg Therapeutics, Inc.	150,990	$8,295,390
5	PRAX	Praxis Precision Medicines, Inc.	24,390	$8,165,528
6	PTGX	Protagonist Therapeutics, Inc	50,570	$6,198,870
7	KRYS	Krystal Biotech, Inc.	16,150	$6,002,470
8	BBIO	BridgeBio Pharma, Inc.	78,497	$5,846,456

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,455,557	61,696	-8.8%	Shares	Sole	2026-08-14
2026-03-31	$15,465,807	67,616	+1.9%	Shares	Sole	2026-05-15
2025-12-31	$14,145,488	66,336	+55.5%	Shares	Sole	2026-02-13
2025-09-30	$8,480,439	42,656	+1278.2%	Shares	Sole	2025-11-17
2021-06-30	$407,147	3,095	0.0%	Shares	Sole	2021-08-17
2021-03-31	$398,883	3,095	-20.5%	Shares	Sole	2021-05-14
2020-12-31	$649,608	3,895	0.0%	Shares	Sole	2021-02-17
2020-09-30	$601,076	3,895	0.0%	Shares	Sole	2020-11-16
2020-06-30	$576,070	3,895	0.0%	Shares	Sole	2020-08-14
2020-03-31	$438,615	3,895	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.